1. Home
  2. IPHA vs LCW Comparison

IPHA vs LCW Comparison

Compare IPHA & LCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPHA
  • LCW
  • Stock Information
  • Founded
  • IPHA 1999
  • LCW 2021
  • Country
  • IPHA France
  • LCW United States
  • Employees
  • IPHA N/A
  • LCW N/A
  • Industry
  • IPHA Biotechnology: Pharmaceutical Preparations
  • LCW Blank Checks
  • Sector
  • IPHA Health Care
  • LCW Finance
  • Exchange
  • IPHA Nasdaq
  • LCW Nasdaq
  • Market Cap
  • IPHA 187.0M
  • LCW 165.8M
  • IPO Year
  • IPHA 2019
  • LCW 2021
  • Fundamental
  • Price
  • IPHA $2.31
  • LCW $10.99
  • Analyst Decision
  • IPHA Strong Buy
  • LCW
  • Analyst Count
  • IPHA 1
  • LCW 0
  • Target Price
  • IPHA $11.50
  • LCW N/A
  • AVG Volume (30 Days)
  • IPHA 5.5K
  • LCW 20.5K
  • Earning Date
  • IPHA 09-12-2024
  • LCW 01-01-0001
  • Dividend Yield
  • IPHA N/A
  • LCW N/A
  • EPS Growth
  • IPHA N/A
  • LCW N/A
  • EPS
  • IPHA N/A
  • LCW N/A
  • Revenue
  • IPHA $68,134,188.00
  • LCW N/A
  • Revenue This Year
  • IPHA N/A
  • LCW N/A
  • Revenue Next Year
  • IPHA $105.84
  • LCW N/A
  • P/E Ratio
  • IPHA N/A
  • LCW N/A
  • Revenue Growth
  • IPHA 6.88
  • LCW N/A
  • 52 Week Low
  • IPHA $1.81
  • LCW $10.57
  • 52 Week High
  • IPHA $3.15
  • LCW $11.03
  • Technical
  • Relative Strength Index (RSI)
  • IPHA 52.05
  • LCW 59.38
  • Support Level
  • IPHA $2.14
  • LCW $11.00
  • Resistance Level
  • IPHA $2.34
  • LCW $11.02
  • Average True Range (ATR)
  • IPHA 0.14
  • LCW 0.01
  • MACD
  • IPHA 0.00
  • LCW -0.00
  • Stochastic Oscillator
  • IPHA 55.88
  • LCW 75.00

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

About LCW Learn CW Investment Corporation

Learn CW Investment Corp is a blank check company. It is formed for the purpose of effecting a merger, consolidation, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Share on Social Networks: